To download the latest issue
May 21st, 2014
Quantapore closed a Series B with a total investment volume of up to $35M from undisclosed investors
Quantapore Inc. is developing a novel, nanopore based nucleic acid sequencing technology.
Unlike other nanopore approaches, Quantapore utilizes an optical read out which results in lower cost and higher throughput compared to electrical data acquisition.
More MEDTECH news